“…In addition, an ago7 mutant has increased susceptibility to specific derivatives of VSR-defective TCV (Qu et al, 2008), and ago4 mutants are more susceptible to TRV (Ma et al, 2015). By contrast, AGO2 appears to be broadly required for antiviral defenses, having been shown to be involved in defense against a wide range of viruses, including CMV, TCV, TRV, PVX, Turnip mosaic virus (TuMV), and Tomato bushy stunt virus (Harvey et al, 2011;Jaubert et al, 2011;Scholthof et al, 2011;Wang et al, 2011;Carbonell et al, 2012;Zhang et al, 2012;Ma et al, 2015). RISC complexes containing AGO1, 2, 3, or 5 act on viruses in in vitro Tombuvirus replication assays, and AGO1, 2, 3, 4, 5, and 9 can all bind to sRNAs derived from viruses or viroids (Takeda et al, 2008;Wang et al, 2011;Schuck et al, 2013;Minoia et al, 2014).…”